EGFR and neoplasm: In addition, AREG works as a key amplifier of EGFR signalling, being able to integrate signals from other low-affinity EGFR ligands at the receptor state, generating multiple signalling modalities that induce pathological processes such as fibrotic disorders and tumour invasion [22,32].